These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26873700)

  • 1. Fake anti-malarials: start with the facts.
    Kaur H; Clarke S; Lalani M; Phanouvong S; Guérin P; McLoughlin A; Wilson BK; Deats M; Plançon A; Hopkins H; Miranda D; Schellenberg D
    Malar J; 2016 Feb; 15():86. PubMed ID: 26873700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.
    Tivura M; Asante I; van Wyk A; Gyaase S; Malik N; Mahama E; Hostetler DM; Fernandez FM; Asante KP; Kaur H; Owusu-Agyei S
    BMC Pharmacol Toxicol; 2016 Oct; 17(1):48. PubMed ID: 27788677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study.
    Ozawa S; Evans DR; Higgins CR; Laing SK; Awor P
    Malar J; 2019 Jan; 18(1):5. PubMed ID: 30626380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea.
    Kaur H; Allan EL; Mamadu I; Hall Z; Green MD; Swamidos I; Dwivedi P; Culzoni MJ; Fernandez FM; Garcia G; Hergott D; Monti F
    BMJ Glob Health; 2017; 2(4):e000409. PubMed ID: 29082025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria.
    Kaur H; Allan EL; Mamadu I; Hall Z; Ibe O; El Sherbiny M; van Wyk A; Yeung S; Swamidoss I; Green MD; Dwivedi P; Culzoni MJ; Clarke S; Schellenberg D; Fernández FM; Onwujekwe O
    PLoS One; 2015; 10(5):e0125577. PubMed ID: 26018221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality Testing of Artemisinin-Based Antimalarial Drugs in Myanmar.
    Guo S; Kyaw MP; He L; Min M; Ning X; Zhang W; Wang B; Cui L
    Am J Trop Med Hyg; 2017 Oct; 97(4):1198-1203. PubMed ID: 28820713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
    O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
    Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model.
    Jackson KD; Higgins CR; Laing SK; Mwila C; Kobayashi T; Ippolito MM; Sylvia S; Ozawa S
    BMC Public Health; 2020 Jul; 20(1):1083. PubMed ID: 32646393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to artemisinin combination therapy for malaria in remote areas of Cambodia.
    Yeung S; Van Damme W; Socheat D; White NJ; Mills A
    Malar J; 2008 May; 7():96. PubMed ID: 18510724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.
    Kuemmerle A; Dodoo AN; Olsson S; Van Erps J; Burri C; Lalvani PS
    Malar J; 2011 Mar; 10():57. PubMed ID: 21388536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
    Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
    Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Falsified antimalarials: a minireview.
    Chaccour C; Kaur H; Del Pozo JL
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):505-9. PubMed ID: 25683870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-malarial market and policy surveys in sub-Saharan Africa.
    Diap G; Amuasi J; Boakye I; Sevcsik AM; Pecoul B
    Malar J; 2010 Apr; 9 Suppl 1(Suppl 3):S1. PubMed ID: 20423536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Artemisinin-Containing Antimalarials in Tanzania's Private Sector--Results from a Nationally Representative Outlet Survey.
    Act Consortium Drug Quality Project Team And The Impact Study Team
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):75-86. PubMed ID: 25897065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana.
    Klein EY; Lewis IA; Jung C; Llinás M; Levin SA
    Malar J; 2012 Apr; 11():110. PubMed ID: 22482747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
    Ladner J; Davis B; Audureau E; Saba J
    Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The malaria testing and treatment landscape in mainland Tanzania, 2016.
    ; Michael D; Mkunde SP
    Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
    El-Duah M; Ofori-Kwakye K
    J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.